Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Sci Rep ; 8(1): 13373, 2018 09 06.
Artigo em Inglês | MEDLINE | ID: mdl-30190613

RESUMO

Tuberous sclerosis complex (TSC), a heritable neurodevelopmental disorder, is caused by mutations in the TSC1 or TSC2 genes. To date, there has been little work to elucidate regional TSC1 and TSC2 gene expression within the human brain, how it changes with age, and how it may influence disease. Using a publicly available microarray dataset, we found that TSC1 and TSC2 gene expression was highest within the adult neo-cerebellum and that this pattern of increased cerebellar expression was maintained throughout postnatal development. During mid-gestational fetal development, however, TSC1 and TSC2 expression was highest in the cortical plate. Using a bioinformatics approach to explore protein and genetic interactions, we confirmed extensive connections between TSC1/TSC2 and the other genes that comprise the mammalian target of rapamycin (mTOR) pathway, and show that the mTOR pathway genes with the highest connectivity are also selectively expressed within the cerebellum. Finally, compared to age-matched controls, we found increased cerebellar volumes in pediatric TSC patients without current exposure to antiepileptic drugs. Considered together, these findings suggest that the cerebellum may play a central role in TSC pathogenesis and may contribute to the cognitive impairment, including the high incidence of autism spectrum disorder, observed in the TSC population.


Assuntos
Cerebelo/metabolismo , Regulação Neoplásica da Expressão Gênica , Transtornos do Neurodesenvolvimento/metabolismo , Proteína 1 do Complexo Esclerose Tuberosa/biossíntese , Proteína 2 do Complexo Esclerose Tuberosa/biossíntese , Esclerose Tuberosa/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cerebelo/patologia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade , Transtornos do Neurodesenvolvimento/patologia , Esclerose Tuberosa/patologia
2.
Neoplasma ; 63(5): 687-95, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27468872

RESUMO

Renal angiomyolipomas (AMLs) are uncommon benign tumors that occur sporadically or as a part of tuberous sclerosis complex (TSC). Risk of life threatening hemorrhage is the main clinical concern. Although several evidences suggest that hyper-activation of the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway is crucial for these tumors, modulation of other metabolic pathways might affect tumor growth and progression. Therefore, we aimed to further characterize angiomyolipoma by TSC1/TSC2 expression, hypoxic status, expression of endoplasmic reticulum (ER) stress markers and calcium transport from the ER through the inositol 1,4,5-trisphosphate (IP3) receptors. Despite our expectations, angiomyolipoma were not hypoxic, as determined by absent expression of the carbonic anhydrase IX, which is a reliable marker of hypoxia. This was in accord with very low expression of TSC1 (that is associated with HIF activation) and a high expression of TSC2. Angiomyolipoma specimens also showed a significant upregulation of an anti-apoptotic marker Bcl2 when compared to healthy kidney tissue supporting the induction of pro-survival signaling. Moreover, angiomyolipoma specimens showed the overexpression of the ER stress markers XBP1, CHOP and ATF4 as well as of the mediators of calcium metabolism, namely the type 1 and 2, but not the type 3 IP3 receptors. These data suggest that the ER stress response, survival and calcium metabolism-related pathways but not hypoxia is an important component of the angiomyolipoma pathogenesis.


Assuntos
Angiomiolipoma/patologia , Sinalização do Cálcio/fisiologia , Estresse do Retículo Endoplasmático/fisiologia , Receptores de Inositol 1,4,5-Trifosfato/metabolismo , Neoplasias Renais/patologia , Fator 4 Ativador da Transcrição/biossíntese , Antígenos de Neoplasias/biossíntese , Anidrase Carbônica IX/biossíntese , Hipóxia Celular/fisiologia , Humanos , Rim/patologia , Alvo Mecanístico do Complexo 1 de Rapamicina/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Fator de Transcrição CHOP/biossíntese , Esclerose Tuberosa/patologia , Proteína 1 do Complexo Esclerose Tuberosa/biossíntese , Proteína 2 do Complexo Esclerose Tuberosa/biossíntese , Proteína 1 de Ligação a X-Box/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA